Recurrent Gastrointestinal Hemorrhage in Children with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with Dasatinib: Case Reports

Dasatinib, a second-line tyrosine kinase inhibitor (TKI), has been widely used in chronic myeloid leukemia (CML) and Philadelphia-positive B-cell acute lymphoblastic leukemia (Ph + B-ALL). Although dasatinib has been well tolerated, side effects including hemorrhage are not rare. Cases of bleeding d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xin, Guo, Yuxia, Shen, Yali, Xiao, Jianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035504/
https://www.ncbi.nlm.nih.gov/pubmed/32095296
http://dx.doi.org/10.1155/2020/5678210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035504/
https://www.ncbi.nlm.nih.gov/pubmed/32095296
http://dx.doi.org/10.1155/2020/5678210

Ejemplares similares